News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

GlaxoSmithKline (GSK) Chief Andrew Witty Calls For Drugs Overhaul


6/22/2010 8:17:49 AM

Telegraph -- Andrew Witty, the chief executive of GlaxoSmithKline, has given his backing to a radical overhaul of drug regulation that could see a single European body taking greater control of new drug approvals in the UK.

Read at Telegraph
Read at Wall Street Journal


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES